The role of nafamostat mesylate anticoagulation in continuous kidney replacement therapy for critically ill patients with bleeding tendencies: a retrospective study on patient outcomes and safety
Background Continuous kidney replacement therapy (CKRT) is crucial in the management of acute kidney injury in intensive care units (ICUs). Nonetheless, the optimal anticoagulation strategy for patients with bleeding tendencies remains debated. This study aimed to evaluate patient outcomes and safet...
Saved in:
Main Authors: | Taeil Kim (Author), Dong Eon Kim (Author), Eun Mi Jo (Author), Yeji Lee (Author), Da Woon Kim (Author), Hyo Jin Kim (Author), Eun Young Seong (Author), Sang Heon Song (Author), Harin Rhee (Author) |
---|---|
Format: | Book |
Published: |
The Korean Society of Nephrology,
2024-07-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Anticoagulation application of nafamostat mesylate in patients on continuous renal replacement therapy at a high risk of hemorrhage
by: Jia-rong Ding, et al.
Published: (2024) -
Differences in the incidence, characteristics, and outcomes of patients with acute kidney injury in the medical and surgical intensive care units
by: Yeji Lee, et al.
Published: (2024) -
Development of Nafamostat Mesylate Immediate-Release Tablet by Drug Repositioning Using Quality-by-Design Approach
by: Hyeon-A Kim, et al.
Published: (2022) -
Hospital mortality and prognostic factors in critically ill patients with acute kidney injury and cancer undergoing continuous renal replacement therapy
by: Da Woon Kim, et al.
Published: (2022) -
Cardiac arrest caused by nafamostat mesilate
by: Hyo Shik Kim, et al.
Published: (2016)